1. Home
  2. FEIM vs DSGN Comparison

FEIM vs DSGN Comparison

Compare FEIM & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Frequency Electronics Inc.

FEIM

Frequency Electronics Inc.

HOLD

Current Price

$74.43

Market Cap

722.9M

Sector

Industrials

ML Signal

HOLD

Logo Design Therapeutics Inc.

DSGN

Design Therapeutics Inc.

HOLD

Current Price

$13.99

Market Cap

853.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FEIM
DSGN
Founded
1961
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
722.9M
853.8M
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
FEIM
DSGN
Price
$74.43
$13.99
Analyst Decision
Buy
Strong Buy
Analyst Count
2
4
Target Price
$51.50
$15.25
AVG Volume (30 Days)
410.1K
490.1K
Earning Date
03-11-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$63,227,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$21.73
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$25.55
$4.23
52 Week High
$80.52
$17.25

Technical Indicators

Market Signals
Indicator
FEIM
DSGN
Relative Strength Index (RSI) 58.83 59.73
Support Level $44.48 $9.78
Resistance Level $76.84 $17.10
Average True Range (ATR) 6.28 0.73
MACD 0.73 0.15
Stochastic Oscillator 75.17 86.70

Price Performance

Historical Comparison
FEIM
DSGN

About FEIM Frequency Electronics Inc.

Frequency Electronics Inc is a world leader in precision time and frequency generation technology, which is incorporated into commercial and U.S. Government satellites, Command, Control, Communication, Computer, Intelligence, Surveillance and Reconnaissance, and Electronic Warfare systems. Its technology is used for a wide range of space and non-space applications. The company has two segments FEI-NY, and FEI-Zyfer. Majority of revenue come from FEI-NY which provides precision time, frequency generation and synchronization products and subsystems that are found on-board satellites, in ground-based communication systems and imbedded in mobile platforms operated by the U.S. military.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering the research and development of GeneTAC molecules, which are a novel class of small-molecule gene targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. Its pipeline includes Friedreich Ataxia, FECD, DM1, and Huntington's Disease. The company operates in one operating and reportable segment focused on utilizing the company's proprietary GeneTAC platform to design and develop therapeutic candidates for inherited diseases driven by nucleotide repeat expansion.

Share on Social Networks: